| This week's sponsor is CMIC Group. | | | |
Today's Rundown Ginkgo raises $290M to fuel synthetic biology expansion IPO take 2: Kindler's Centrexion restarts bid to fund pain trial Could a combo treatment boost KRAS inhibitors in lung cancer? [Sponsored] Solutions to Today’s Biomanufacturing Challenges Medicxi founds biotech to Divide & Conquer tough solid tumors Boundless Bio uncloaks with $46M to create new cancer drugs aimed at extrachromosomal DNA Spruce scores phase 2a win for rare disease drug, gears up for 2020 Black Diamond grabs trio of new R&D execs as it barrels toward the clinic Success of nearly half of European cancer drug trials 'exaggerated' due to bias: report DeepMind's health team makes the jump to Google with some NHS partnerships in tow Zolgensma trial death unrelated to gene therapy, Novartis says, touting new data Featured Story | | | Thursday, September 19, 2019 Ginkgo Bioworks has raised $290 million. The synthetic biology unicorn will use the series E funds to continue building on a cell programming platform it thinks can upend multiple industries. |
|
|---|
|
| This week's sponsor is Millipore Sigma. | | | |
Top Stories Thursday, September 19, 2019 Centrexion Therapeutics has restarted its attempt to list on the Nasdaq. The Jeff Kindler-helmed biotech pulled the plug on a planned IPO last year but now hopes to find investors more amenable to its bid to raise money for a phase 3 pain program. Wednesday, September 18, 2019 KRAS made a splash at this year’s ASCO after Amgen’s early data for first-to-clinic inhibitor AMG 510 triggered blockbuster chatter. Now one research team has early evidence that the combo could further increase KRAS inhibitors’ therapeutic effects in lung cancer. Monday, September 16, 2019 With more complex molecules in development, changing capacity needs, uncertain forecasts and increased competition, the market demands flexibility and innovative approaches to address these challenges. Wednesday, September 18, 2019 Moncef Slaoui and his colleagues at Medicxi have taken the wraps off a new oncology startup, Divide & Conquer. The biotech wants to interrupt the cell-to-cell communication that may make some solid tumors hard to treat. Thursday, September 19, 2019 Boundless Bio was founded on a discovery that a group of cancer-driving mutations called amplifications occur in extrachromosomal DNA, or DNA that resides outside of the chromosome in cancer cells. Thursday, September 19, 2019 New phase 2a data show Spruce's lead drug reduced the level of three hormones overproduced by patients with congenital adrenal hyperplasia, teeing it up for its next trial slated to start in 2020. Thursday, September 19, 2019 After a whirlwind year and two quick-fire raises, cancer startup Black Diamond Therapeutics has nabbed Yumanity, Merck KGaA and SR One veterans to help head up its research work. Thursday, September 19, 2019 Trials for cancer drugs undertaken in Europe in the mid-2010s were flawed to such a degree as to “raise questions” over their true benefit to patients, according to a new report out this week from British science journal The BMJ. Wednesday, September 18, 2019 About 10 months after first announcing the move, Google has subsumed the healthcare-focused efforts of U.K.-based artificial intelligence firm DeepMind—and with them, its data-sharing partnerships with multiple National Health Service hospitals. Thursday, September 19, 2019 Novartis unveiled new long-term Zolgensma data that could dispel worries spawned by last month's data manipulation scandal. And at the same time, it put out news to clear up concern that a trial patient's death was related to Zolgensma treatment. | This week's sponsor is LabConnect. | | |
LabConnect is the preeminent provider of central laboratory support services for logistically and analytically complex studies - customizable to meet the unique needs of your clinical trials. We are your connection to confidence. Contact us today. |
Enrollment Showcase | | | October 23-25, 2019 | Chicago, IL | Presented by Biotech Primer BioImmersion: Biotech for the Non-Scientist is a three-day, in-depth course that delves into the scientific details on a broad number of biotechnology topics. Register today! |
|
|---|
|
Resources Sponsored by: Reprints Desk, Inc. Slashing your R&D costs is easier than you think. Sponsored by: Roche and IQVIA A global landscape study of funding trends and innovations. Sponsored by: BioAnalytix Download the White Paper and learn how detailed characterization can guide successful development of gene therapy products. Sponsored by: Blue Matter, strategic consultants in the life sciences White paper providing an overview of precision medicine in oncology, as well as a look ahead at future developments and keys to success for pharmaceutical and diagnostics companies. Sponsored by: Patheon, by Thermo Fisher Scientific Avoid potential risks to the patient as well as costly interruptions during development. Sponsored by: Outer Edge Technology Find out how outsourcing your IT requirements enhances the bottom line while creating strategic advantage. Sponsored by: Vineti Developing a cell therapy, gene therapy, or personalized cancer vaccine? Modern data management makes a critical difference in operational and regulatory outcomes. This whitepaper will help your team leverage the latest data strategies for success. Sponsored by: AlphaSense AI-powered research tools are making it easier to source confident healthcare market intelligence with accuracy and efficiency -- download now to learn more about improving your competitive research strategy. Sponsored by: Elemental Machines Your lab is talking to you, are you listening? Sponsored by: Frenova Want to be sure your renal research protocol design is fit for the real world? Sponsored by: Recro Gainesville Vetting CDMOs but unsure what to look for in prospective partners’ multiproduct facilities? Sponsored by: Accenture Clinical trials are one of the pharma industry’s most painful and costly processes. Read how technology could transform the trial process from nine years to a matter of hours. Sponsored by: Baxter BioPharma Solutions Check out Baxter BioPharma Solutions’ whitepaper to learn considerations and options for developing a product in a prefilled syringe. Sponsored by: Alexander Group From sales headcount and budgets to new product launches and saying “yes” to millennials, hear the top 7 topics that are trending in sales compensation. Sponsored by: Kinaxis Download this life sciences industry spotlight to discover how concurrent planning can help you overcome complex supply chain challenges to drive down costs and improve efficiency. Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. U.S. Healthcare Compliance Certificate Program October 14-17, 2019 | Newark, New Jersey European Healthcare Compliance Certificate Program October 21-25, 2019 | Paris, France BioBasics: Biotech For The Non-Scientist Oct 22-23, 2019 | San Diego, CA BioImmersion: Biotech for the Non-Scientist October 23-25, 2019 | Chicago, IL 4th FierceBiotech Drug Development Forum October 28-29, 2019 | Boston, MA Drug Development Immersion November 7-8, 2019 | Boston, MA Advanced Therapies: Immunotherapies, Cell Therapies and Gene Therapies November 15, 2019 | Boston, MA Drug Development Boot Camp® 2019 November 20-21, 2019 | Boston, MA | Register NOW and start Pre-Boot Camp Preparation! | 